EPFL Investor Day 2024

10 Dec 2024 | Lausanne, Switzerland

InvestmentUpdated on 5 December 2024

Limula is going commercial (ranked #14 in TOP100 Swiss Startups)

Luc Henry

CEO at Limula

Epalinges, Switzerland

About

We generated revenues in 2025, selling an MVP and pilots on our technology, now raising a CHF 10m Series A to build devices, convert traction into recurring, and grow our overall pipeline of customers.

We have closed a Seed round of CHF/€ 7.2m in May 2024, hit all planned technical and commercial milestones, looking at closing a CHF/€ 10m Series A in Q1 2026 to establish a commercial team and convert traction into recurring revenues when our product is ready to ship to already committed customers (several LOI from pharma, biotech and hospitals).

We value building relationships with investors, having regular conversations, laying out the plan, reporting on milestones hit and raising capital when most relevant to take Limula to the next chapter. Now is the time!

Contact: Luc Henry, CEO luc.henry@limula.ch

Stage

  • Early stage.

Applies to

  • Biotech and Pharma

Organisation

Limula

Startup

Epalinges, Switzerland